Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Beyond clinical endpoints: Rethinking ALS drug development through disease biology

Beyond clinical endpoints: Rethinking ALS drug development through disease biology

  • September 11, 2026

After decades of hard-won progress, ALS drug development is entering a new era, building on established efficacy measures like survival and ALSFRS-R with biology-driven science that captures the full heterogeneity of the disease.

Leave A Comment

Fields (*) Mark are Required